An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system
- 1 July 2000
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 6 (7) , 808-811
- https://doi.org/10.1038/77543
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The human endogenous local anesthetic-like factor (ELLF) is functionally neutralized by serum albuminNeuroscience Letters, 1996
- Axonal channelopathiesNeurology, 1996
- Cerebrospinal fluid from multiple sclerosis patients inactivates neuronal Na+ currentBrain, 1996
- Pathology of the motor‐sensory axonal Guillain‐Barré syndromeAnnals of Neurology, 1996
- Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channelsMuscle & Nerve, 1995
- Antibodies against GM1 ganglioside affect K+ and NA+ currents in isolated rat myelinated nerve fibersAnnals of Neurology, 1995
- Sodium channel blockade by antibodies: A new mechanism of neurological disease?Annals of Neurology, 1995
- Factors in the cerebrospinal fluid of multiple sclerosis patients interfering with voltage-dependent sodium channelsNeuroscience Letters, 1993
- Lidocaine unmasks silent demyelinative lesions in multiple sclerosisNeurology, 1992
- The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluidPflügers Archiv - European Journal of Physiology, 1992